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LETTERS TO THE EDITORLATE LEFTATRIAL
THROMBOSIS OFAN
AMPLATZER PATENT
FORAMEN OVALE OCCLUDER
MAY BE THE RESULT OF
KOUNIS HYPERSENSITIVITY-
ASSOCIATED SYNDROME
To the Editor:
In the very interesting report by
Klotz and colleagues1 published in
this Journal, a patient with a patent fo-
ramen ovale that was successfully oc-
cluded with an Amplatzer occluder
had a large thrombosis develop on
the atrial disk of the device 33 months
after the initial implantation. Al-
though Klotz and colleagues1 did not
refer to the etiology of thrombus for-
mation, several such causes have
been reported, including incorrect
device placement, device size, device
instability, anticoagulation, and anti-
platelet therapy monitoring.
The Amplatzer closure device is
made from nitinol, which is a nickel-
titanium alloy. Nickel allergy is quite
common, and in a recent report the
overall prevalence was found to be
24.6%. Titanium hypersensitivity, al-
though low, has been seen in dental
procedures and induces implant fail-
ure.2 The described patient received
also aspirin and warfarin on several
occasions, both of which are well-
known antigenic compounds.3 It is
known that mast cells bring, on their
surface, 500,000 to 1 million IgE mol-
ecules, and to degranulate they need
2000 of these molecules, which is
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can be made by antigens of different
specificities, as happens in patients
with metal device implantation. It
looks likely that the more antigens to
which a patient with metal device im-
plantation, is exposed the more easily
and quickly the degranulation occurs.2
Nickel and titanium ions acting as
antigens can activate platelets to
release proinflammatory, prothrom-
botic, adhesive, and aggregatory
mediators to induce thrombus forma-
tion.4 Platelet activation is taking
place through stimulation of some
known receptors in the platelet sur-
face, such as receptors for adenosine
diphosphate, for thromboxane, for
thrombin, for serotonin, and for epi-
nephrine, and through some less-
known receptors, such as receptors
for platelet activating factor, for hista-
mine, and for high-affinity and low-
affinity IgE receptors FCεRI and
FCεRII.2
Thrombus formation after left atrial
appendage occulsion with an Amplat-
zer cardiac plug device can occur
months after the procedure. Nickel
allergy to intracardiac devices has
caused systemic allergic reactions
confirmed by patch tests to nitinol,
which necessitated the removal of
those devices. A device syndrome
resembling Kounis syndrome and
consisting of chest discomfort, exer-
tional dyspnea, palpitations, asthenia,
atrial fibrillation was reported in 8 of
9 patients in a series after Amplatzer
implantation. Those patients had pos-
itive patch skin test reactions to
nickel.5
Although the rate of thrombosis
complicating such devices might be
low, we are still in the learning curve,
and additional research is needed to
prevent and treat such consequences.
We recommend avoidance of metal
device implantation in patients with
known hypersensitivity or contraindi-
cation to any structurally related
compound and to drugs these patients
would need to take after
implantation.ardiovascular Surgery c July 2012Nicholas G. Kounis,
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My coauthors and I read with
great interest the Letter to the Editor
by Kounis and colleagues regarding
our case report of a left atrial throm-
bosis of an Amplatzer patent fora-
men ovale (PFO) occluder (St Jude
Medical, St Paul, Minn) 33 months
after implantation.1 Kounis and col-
leagues hypothesized that this
thrombosis could the result of the
Kounis hypersensitivity-associated
syndrome. This syndrome describes,
among others, an allergic reaction
to intracardiac metal devices (such
as PFO occluders and stents) con-
taining nickel or other metals.2
We appreciate the input fromKounis
and colleagues, which might give
